Search research articles
Contact Us
Filters
Showing results (81-90 of 91) with videos related to
Page
of 10
Sort By:
The New England Journal of Medicine
|
December 28, 1989
Survival in children with perinatally acquired human immunodeficiency virus type 1 infection
G B Scott, C Hutto, R W Makuch, et al.
American Journal of Obstetrics and Gynecology
|
May 1, 1993
The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: phase I acquired immunodeficiency syndrome clinical trials group study (protocol 082). Zidovudine Collaborative Working Group
M J O'Sullivan, P J Boyer, G B Scott, et al.
The Journal of Pediatrics
|
March 1, 1991
A hospital-based prospective study of perinatal infection with human immunodeficiency virus type 1
C Hutto, W P Parks, S H Lai, et al.
AIDS Research and Human Retroviruses
|
May 20, 1998
Association of antibody reactivity to ELDKWA, a glycoprotein 41 neutralization epitope, with disease progression in children perinatally infected with HIV type 1
R B Geffin, G B Scott, M Melenwick, et al.
The New England Journal of Medicine
|
April 21, 1991
A multicenter trial of oral zidovudine in children with advanced human immunodeficiency virus disease. The Protocol 043 Study Group
R E McKinney, M A Maha, E M Connor, et al.
Pediatrics
|
April 1, 1997
A descriptive survey of pediatric human immunodeficiency virus-infected long-term survivors
K Nielsen, G McSherry, A Petru, et al.
The Journal of Infectious Diseases
|
August 1, 1988
Fatal measles pneumonia without rash in a child with AIDS
L E Markowitz, F W Chandler, E O Roldan, et al.
Pediatrics
|
February 2, 1999
Planning for children whose parents are dying of HIV/AIDS. American Academy of Pediatrics. Committee on Pediatric AIDS, 1998-1999
C Wilfert, J E Aronson, D T Beck, et al.
The Journal of Pediatrics
|
April 1, 1990
Safety and tolerance of intermittent intravenous and oral zidovudine therapy in human immunodeficiency virus-infected pediatric patients. Pediatric Zidovudine Phase I Study Group
R E McKinney, P A Pizzo, G B Scott, et al.
Leukemia
|
March 28, 2015
Oncolytic reovirus enhances rituximab-mediated antibody-dependent cellular cytotoxicity against chronic lymphocytic leukaemia
C Parrish, G B Scott, G Migneco, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 91) with videos related to
Sort By:
Page
of 10
The New England Journal of Medicine
|
December 28, 1989
Survival in children with perinatally acquired human immunodeficiency virus type 1 infection
G B Scott, C Hutto, R W Makuch, et al.
American Journal of Obstetrics and Gynecology
|
May 1, 1993
The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: phase I acquired immunodeficiency syndrome clinical trials group study (protocol 082). Zidovudine Collaborative Working Group
M J O'Sullivan, P J Boyer, G B Scott, et al.
The Journal of Pediatrics
|
March 1, 1991
A hospital-based prospective study of perinatal infection with human immunodeficiency virus type 1
C Hutto, W P Parks, S H Lai, et al.
AIDS Research and Human Retroviruses
|
May 20, 1998
Association of antibody reactivity to ELDKWA, a glycoprotein 41 neutralization epitope, with disease progression in children perinatally infected with HIV type 1
R B Geffin, G B Scott, M Melenwick, et al.
The New England Journal of Medicine
|
April 21, 1991
A multicenter trial of oral zidovudine in children with advanced human immunodeficiency virus disease. The Protocol 043 Study Group
R E McKinney, M A Maha, E M Connor, et al.
Pediatrics
|
April 1, 1997
A descriptive survey of pediatric human immunodeficiency virus-infected long-term survivors
K Nielsen, G McSherry, A Petru, et al.
The Journal of Infectious Diseases
|
August 1, 1988
Fatal measles pneumonia without rash in a child with AIDS
L E Markowitz, F W Chandler, E O Roldan, et al.
Pediatrics
|
February 2, 1999
Planning for children whose parents are dying of HIV/AIDS. American Academy of Pediatrics. Committee on Pediatric AIDS, 1998-1999
C Wilfert, J E Aronson, D T Beck, et al.
The Journal of Pediatrics
|
April 1, 1990
Safety and tolerance of intermittent intravenous and oral zidovudine therapy in human immunodeficiency virus-infected pediatric patients. Pediatric Zidovudine Phase I Study Group
R E McKinney, P A Pizzo, G B Scott, et al.
Leukemia
|
March 28, 2015
Oncolytic reovirus enhances rituximab-mediated antibody-dependent cellular cytotoxicity against chronic lymphocytic leukaemia
C Parrish, G B Scott, G Migneco, et al.
Page
of 10